CLOVER HEALTH INVESTMENTS CORP

NASDAQ: CLOV (Clover Health Investments, Corp)

Kemas kini terakhir: 27 Nov, 6:18PM

2.45

0.03 (1.24%)

Penutupan Terdahulu 2.42
Buka 2.43
Jumlah Dagangan 3,920,016
Purata Dagangan (3B) 8,900,028
Modal Pasaran 1,265,861,248
Harga / Pendapatan (P/E Ke hadapan) 104.17
Harga / Jualan (P/S) 0.710
Harga / Buku (P/B) 3.77
Julat 52 Minggu
2.12 (-13%) — 4.87 (98%)
Tarikh Pendapatan 4 Nov 2025
Margin Keuntungan -1.69%
Margin Operasi (TTM) -0.28%
EPS Cair (TTM) -0.040
Pertumbuhan Hasil Suku Tahunan (YOY) 33.40%
Jumlah Hutang/Ekuiti (D/E MRQ) 1.07%
Nisbah Semasa (MRQ) 1.54
Aliran Tunai Operasi (OCF TTM) -7.38 M
Aliran Tunai Bebas Leveraj (LFCF TTM) 126.31 M
Pulangan Atas Aset (ROA TTM) -2.43%
Pulangan Atas Ekuiti (ROE TTM) -7.75%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Healthcare Plans (US) Menaik Menurun
Healthcare Plans (Global) Menaik Menurun
Stok Clover Health Investments, Corp Menaik Menurun

AISkor Stockmoo

-0.3
Konsensus Penganalisis 1.5
Aktiviti Orang Dalam NA
Volatiliti Harga 0.5
Purata Bergerak Teknikal 1.0
Osilator Teknikal -4.0
Purata -0.25

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
CLOV 1 B - - 3.77
MRAI 24 M - - 1.49
ALHC 4 B - - 23.61

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.

Sektor Healthcare
Industri Healthcare Plans
Gaya Pelaburan Small Value
% Dimiliki oleh Orang Dalam 3.90%
% Dimiliki oleh Institusi 26.16%
Julat 52 Minggu
2.12 (-13%) — 4.87 (98%)
Median 3.70 (51.02%)
Jumlah 1 Beli
Syarikat Tarikh Harga Sasaran Panggilan Harga @ Panggilan
Canaccord Genuity 06 Nov 2025 3.70 (51.02%) Beli 2.61

Tiada data dalam julat masa ini.

Tarikh Jenis Butiran
17 Nov 2025 Pengumuman Clover Health to Participate in Upcoming 2025 Citi Global Healthcare Conference
04 Nov 2025 Pengumuman Clover Health Reports Third Quarter 2025 Results
31 Oct 2025 Pengumuman Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service
30 Oct 2025 Pengumuman Primary Care Physician Use of Counterpart Assistant (CA) Technology Associated With Earlier Diagnosis And Less Frequent Hospitalization In Underserved Populations
22 Oct 2025 Pengumuman Clover Health to Participate in Upcoming 2025 UBS Global Healthcare Conference
15 Oct 2025 Pengumuman Clover Health’s 2026 Medicare Advantage Plans Champion Affordability and Choice
14 Oct 2025 Pengumuman Counterpart Health Expands Proven Flywheel for HEDIS Excellence to Third-Party Partners
09 Oct 2025 Pengumuman Clover Health Comments on 2026 Medicare Advantage Star Ratings and Trajectory for Increasing Profitability into 2027
07 Oct 2025 Pengumuman Clover Health to Report Third Quarter 2025 Financial Results on November 4, 2025
06 Oct 2025 Pengumuman Counterpart Health Expands Leadership to Accelerate Enterprise Partnerships and Regional Adoption of AI-Powered Platform Counterpart Assistant
25 Sep 2025 Pengumuman Counterpart Assistant Gets Conversational
18 Sep 2025 Pengumuman Clover Health Celebrates the Election of Dr. Ian Duncan, Clover MA Board Member, as the 2025-2026 President-Elect and Vice-Chair of the Society of Actuaries
16 Sep 2025 Pengumuman Clover Health Launches New Portal Availity® Essentials™ to Empower Providers and Improve the Patient Experience
09 Sep 2025 Pengumuman Counterpart Health Launches Integrated Scribing, Supercharging Counterpart Assistant with Smarter, Seamless Scribing Built for Value-Based Care
Papar semua

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda